Overview
Nausea and vomiting are common adverse effects associated with various medications, impacting patient adherence and quality of life 1.Diagnosis
Clinical history and medication review essential for identifying drug-induced nausea and vomiting 1.
No specific diagnostic tests; symptoms often correlate with recent drug initiation or dosage changes 1.Management
First-line treatments: Antiemetic drugs such as 5-HT3 receptor antagonists (e.g., ondansetron 8 mg PO/IV) and dopamine antagonists (e.g., metoclopramide 10 mg PO/IM) 1.
Adjunctive treatments: Consider adding corticosteroids (e.g., dexamethasone 4 mg IV) for severe cases or those refractory to initial therapy 1.Special Populations
Pregnancy: Limited specific guidance; cautious use of first-line antiemetics with close monitoring; avoid teratogenic drugs 1.
Pediatrics: Dosage adjustments necessary; consult pediatric dosing guidelines for antiemetics 1.
Elderly: Increased risk of side effects; start with lower doses and monitor closely 1.
Comorbidities: Tailor treatment considering interactions and underlying conditions; consult drug interaction databases 1.Key Recommendations
Link electronic health records with claims data to enhance the accuracy of drug exposure and outcome assessment in studies on drug-induced nausea and vomiting (Evidence: Moderate) 1.
Prioritize the use of 5-HT3 receptor antagonists and dopamine antagonists as first-line treatments for managing drug-induced nausea and vomiting (Evidence: Moderate) 1.
Individualize treatment in special populations, particularly adjusting dosages and monitoring closely in elderly patients and pregnant women (Evidence: Expert opinion) 1.References
1 Lin KJ, Schneeweiss S. Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs. Clinical pharmacology and therapeutics 2016. link
2 Collins ME. SPORT database. Medical reference services quarterly 1989. link